Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lassmann

Showing results (61-70 of 373) with videos related to

Pageof 38
Sort By:
Biochimica Et Biophysica Acta|October 4, 2015
Oxidative stress and its impact on neurons and glia in multiple sclerosis lesionsHans Lassmann, Jack van Horssen
FEBS Letters|August 23, 2011
The molecular basis of neurodegeneration in multiple sclerosisHans Lassmann, Jack van Horssen
The Lancet. Neurology|July 10, 2003
The role of nitric oxide in multiple sclerosisKenneth J Smith, Hans Lassmann
Neurology|January 30, 2008
Cortical demyelination in CNS inflammatory demyelinating diseasesHans Lassmann, Claudia F Lucchinetti
Trends in Immunology|March 24, 2004
The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisalHans Lassmann, Richard M Ransohoff
International MS Journal|September 25, 2008
Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?M Bradl, Dr Hans Lassmann
Clinical & Experimental Neuroimmunology|March 28, 2017
Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorderBleranda Zeka, Hans Lassmann, Monika Bradl
Current Opinion in Neurology|February 22, 2018
Mechanisms for lesion localization in neuromyelitis optica spectrum disordersMonika Bradl, Markus Reindl, Hans Lassmann
Journal of Neuroimmunology|September 11, 2018
Neuroinflammatory responses in experimental and human stroke lesionsIsabella Wimmer, Tobias Zrzavy, Hans Lassmann
Brain : a Journal of Neurology|April 25, 2006
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis researchRalf Gold, Christopher Linington, Hans Lassmann
Pageof 38

Showing results (61-70 of 373) with videos related to

Sort By:
Pageof 38
Biochimica Et Biophysica Acta|October 4, 2015
Oxidative stress and its impact on neurons and glia in multiple sclerosis lesionsHans Lassmann, Jack van Horssen
FEBS Letters|August 23, 2011
The molecular basis of neurodegeneration in multiple sclerosisHans Lassmann, Jack van Horssen
The Lancet. Neurology|July 10, 2003
The role of nitric oxide in multiple sclerosisKenneth J Smith, Hans Lassmann
Neurology|January 30, 2008
Cortical demyelination in CNS inflammatory demyelinating diseasesHans Lassmann, Claudia F Lucchinetti
Trends in Immunology|March 24, 2004
The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisalHans Lassmann, Richard M Ransohoff
International MS Journal|September 25, 2008
Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?M Bradl, Dr Hans Lassmann
Clinical & Experimental Neuroimmunology|March 28, 2017
Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorderBleranda Zeka, Hans Lassmann, Monika Bradl
Current Opinion in Neurology|February 22, 2018
Mechanisms for lesion localization in neuromyelitis optica spectrum disordersMonika Bradl, Markus Reindl, Hans Lassmann
Journal of Neuroimmunology|September 11, 2018
Neuroinflammatory responses in experimental and human stroke lesionsIsabella Wimmer, Tobias Zrzavy, Hans Lassmann
Brain : a Journal of Neurology|April 25, 2006
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis researchRalf Gold, Christopher Linington, Hans Lassmann
Pageof 38